HealthEquity Price to Free Cash Flow Ratio 2014-2025 | HQY
Historical price to free cash flow ratio values for HealthEquity (HQY) since 2014.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| HealthEquity Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-07-11 | 94.52 | 29.61 | |
| 2025-04-30 | 85.72 | $3.19 | 26.85 |
| 2025-01-31 | 110.42 | $3.23 | 34.22 |
| 2024-10-31 | 85.25 | $3.29 | 25.90 |
| 2024-07-31 | 78.48 | $2.92 | 26.86 |
| 2024-04-30 | 78.91 | $2.62 | 30.07 |
| 2024-01-31 | 75.58 | $2.30 | 32.86 |
| 2023-10-31 | 71.68 | $2.08 | 34.51 |
| 2023-07-31 | 67.94 | $2.00 | 33.99 |
| 2023-04-30 | 53.45 | $1.56 | 34.24 |
| 2023-01-31 | 60.85 | $1.21 | 50.32 |
| 2022-10-31 | 77.91 | $1.10 | 70.90 |
| 2022-07-31 | 58.17 | $0.72 | 80.47 |
| 2022-04-30 | 62.32 | $0.58 | 106.66 |
| 2022-01-31 | 53.44 | $0.83 | 64.03 |
| 2021-10-31 | 66.18 | $1.03 | 64.33 |
| 2021-07-31 | 73.98 | $1.38 | 53.66 |
| 2021-04-30 | 75.97 | $1.76 | 43.07 |
| 2021-01-31 | 83.55 | $1.55 | 54.03 |
| 2020-10-31 | 51.49 | $1.25 | 41.31 |
| 2020-07-31 | 51.56 | $0.91 | 56.77 |
| 2020-04-30 | 56.27 | $0.70 | 80.26 |
| 2020-01-31 | 66.06 | $1.05 | 62.75 |
| 2019-10-31 | 56.79 | $1.21 | 46.96 |
| 2019-07-31 | 81.98 | $1.53 | 53.73 |
| 2019-04-30 | 67.75 | $1.55 | 43.62 |
| 2019-01-31 | 62.34 | $1.57 | 39.67 |
| 2018-10-31 | 91.80 | $1.34 | 68.64 |
| 2018-07-31 | 75.50 | $1.25 | 60.24 |
| 2018-04-30 | 65.67 | $1.19 | 55.19 |
| 2018-01-31 | 50.62 | $1.06 | 47.54 |
| 2017-10-31 | 50.22 | $1.01 | 49.57 |
| 2017-07-31 | 45.87 | $0.90 | 50.88 |
| 2017-04-30 | 45.52 | $0.74 | 61.60 |
| 2017-01-31 | 46.25 | $0.55 | 84.15 |
| 2016-10-31 | 33.23 | $0.45 | 74.34 |
| 2016-07-31 | 29.52 | $0.41 | 71.18 |
| 2016-04-30 | 25.15 | $0.30 | 84.23 |
| 2016-01-31 | 21.55 | $0.29 | 73.45 |
| 2015-10-31 | 32.71 | $0.26 | 123.85 |
| 2015-07-31 | 33.66 | $0.17 | 201.68 |
| 2015-04-30 | 26.21 | $0.12 | 210.52 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.405B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.077B | 27.58 |
| CVS Health (CVS) | United States | $83.011B | 10.32 |
| Elevance Health (ELV) | United States | $78.142B | 10.08 |
| Cencora (COR) | United States | $57.628B | 20.05 |
| DiDi Global (DIDIY) | China | $23.768B | 25.25 |
| Natera (NTRA) | United States | $22.306B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.229B | 17.22 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.751B | 0.00 |
| Solventum (SOLV) | United States | $13.128B | 13.90 |
| CochLear (CHEOY) | Australia | $12.788B | 0.00 |
| ICON (ICLR) | Ireland | $12.281B | 11.42 |
| Revvity (RVTY) | United States | $12.070B | 20.77 |
| Viatris (VTRS) | United States | $10.857B | 3.73 |
| Medpace Holdings (MEDP) | United States | $9.434B | 25.06 |
| Avantor (AVTR) | United States | $9.336B | 13.56 |
| Sonic Healthcare (SKHHY) | Australia | $8.582B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.038B | 15.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.772B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.024B | 29.58 |
| BrightSpring Health Services (BTSG) | United States | $3.667B | 33.65 |
| Sotera Health (SHC) | United States | $3.375B | 19.18 |
| Surgery Partners (SGRY) | United States | $2.855B | 37.12 |
| Alignment Healthcare (ALHC) | United States | $2.647B | 0.00 |
| Concentras Parent (CON) | United States | $2.621B | 15.15 |
| Organon (OGN) | United States | $2.605B | 2.77 |
| GeneDx Holdings (WGS) | United States | $2.480B | 95.51 |
| Ardent Health (ARDT) | United States | $2.041B | 8.70 |
| Progyny (PGNY) | United States | $2.024B | 44.55 |
| PACS (PACS) | United States | $1.949B | 0.00 |
| Premier (PINC) | United States | $1.767B | 13.41 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.546B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.329B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.160B | 8.82 |
| CareDx (CDNA) | United States | $1.149B | 17.94 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
| Nutex Health (NUTX) | United States | $0.653B | 9.89 |
| Embecta (EMBC) | United States | $0.627B | 4.22 |
| InnovAge Holding (INNV) | United States | $0.567B | 0.00 |
| SBC Medicals (SBC) | United States | $0.552B | 0.00 |
| LifeMD (LFMD) | United States | $0.544B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.486B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.60 |
| Omada Health (OMDA) | $0.461B | 0.00 | |
| So-Young (SY) | China | $0.389B | 0.00 |
| Enhabit (EHAB) | United States | $0.375B | 30.88 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.348B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.338B | 0.00 |
| Beauty Health (SKIN) | United States | $0.257B | 0.00 |
| Oncology Institute (TOI) | United States | $0.256B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 25.00 |
| Pheton Holdings (PTHL) | China | $0.134B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.104B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.023B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |